MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹155 Cr | ₹123 Cr | ₹98 Cr | ₹80 Cr | ₹72 Cr |
What is the latest Long Term Provisions ratio of MANKIND PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹155 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹98 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹72 Cr |
How is Long Term Provisions of MANKIND PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹155 Cr | 25.94 | |
| Mar2024 | ₹123 Cr | 25.78 | |
| Mar2023 | ₹98 Cr | 22.36 | |
| Mar2022 | ₹80 Cr | 10.74 | |
| Mar2021 | ₹72 Cr | - | |
Compare Long Term Provisions of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹82,611.6 Cr | -6.4% | -3% | -4.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -6.4% |
-3% |
-4.5% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses